Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia

References

• Product information for ezetimibe http://www.msppharma.com/msppharma/documents/zetia_pi.pdfAccessed 2010 May 1
   Google Scholar
• National Cholesterol Education Program (NCEP)Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final ReportCirculation20021063143342112485966
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNImplications of recent clinical trials for the National Cholesterol Program Adult Treatment Panel III guidelinesCirculation200411022723915249516
   PubMed Web of Science ®Google Scholar
• HegeleRAGuyJBanMRWangJNPC1 L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibeLipids Health Dis200541616098225
   PubMedGoogle Scholar
• TonkinABarterPBestJNational Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management – 2005Heart Lung Circ20051427529116361000
   PubMedGoogle Scholar
• LakoskiSXuFVegaGLIndices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatinJ Clin Endocrinol Metab20109580080919965915
   PubMed Web of Science ®Google Scholar
• CharlesZPughEBarnettDEzetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolemia: NICE technology appraisal guidanceHeart200894564264318411354
   PubMed Web of Science ®Google Scholar
• SharmaMAnsariMTSoares-WeiserKComparative Effectiveness of Lipid-modifying Agents. Health Services/Technology Assessment TextAHRQ Comparative Effectiveness Reviews Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=hscompeff&part=cer16Accessed 2010 Jun 14
   Google Scholar
• KnoppRHGitterHTruittTEzetimibe reduces low-density lipoprotein cholesterol: results of a phase III, randomized, double-blind, placebo-controlled trialAtherosclerosis20012238
   Google Scholar
• LipkaLKerznerBCrobelliJResults of ezetimibe co-administered with lovastatin in 548 patients with primary hypercholesterolemiaJ Am Coll Cardiol2002399 Suppl B430B
   Google Scholar
• SimonsLMuslinerTQuintoKChoMGumbinerBEzetimibe added to on-going statin therapy for treatment of primary hypercholesterolemia: efficacy and safety in patients with type 2 diabetes mellitusDiabetologia200245 Suppl 2A389
   Google Scholar
• BallantyneCHouriJNotarbatoloAEzetimibe Study GroupEzetimibe co-administered with atorvastatin in 628 patients with primary hypercholesterolemiaJ Am Coll Cardiol200239 Suppl A227A
   Google Scholar
• BaysHWeissSGagneCEzetimibe added to ongoing statin therapy for treatment of primary hypercholesterolemiaJ Am Coll Cardiol200239 Suppl A245A
   Google Scholar
• DavidsonMMcGarryTBettisREzetimibe Study GroupEzetimibe co-administered with simvastatin in 668 patients with primary hypercholesterolemiaJ Am Coll Cardiol200239 Suppl A226A227A
   Google Scholar
• DujovneCHeldJLipkaLLeBeautASureshRVeltriEEzetimibe Study GroupDoes Cholesterol and/or fat intake affect plasma lipid efficacy of ezetimibe?J Am Coll Cardiol200239 Suppl A227A
   Google Scholar
• DujovneCAEttingerMPMcNeerJFEzetimibe Study GroupEfficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemiaAm J Cardiol200290101092109712423709
   PubMed Web of Science ®Google Scholar
• GagneCBaysHEWeissSREzetimibe Study GroupEfficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaAm J Cardiol200290101084109112423708
   PubMed Web of Science ®Google Scholar
• SteinEStenderSMataPEzetimibe Study GroupAchieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatinAm Heart J2004148344745515389231
   PubMed Web of Science ®Google Scholar
• XydakisAMGuytonJRChiouPSteinJLBallantyneCMEffectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemiaAm J Cardiol200494679579715374793
   PubMed Web of Science ®Google Scholar
• VermaakWPintoXPonsonnetDHeterozygous familial hypercholesterolemia: co administration of ezetimibe plus atorvastatinAtherosclerosis200232230231
   Google Scholar
• VermaakWPintoXPonsonnetDEzetimibe Study GroupHeterozygous familial hypercholesterolemia: co administration of ezetimibe plus atorvastatinJ Am Coll Cardiol2003416 Suppl A255A255A12535819
   PubMed Web of Science ®Google Scholar
• WierzbickiASDohertyELumbPJChikGCrookMAEfficacy of ezetimibe in patients with resistant familial hypercholesterolemiaAtherosclerosis20041752S4
   Web of Science ®Google Scholar
• WierzbickiASDohertyELumbPJChikGCrookMAEfficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidemiasCurr Med Res Opin200521333315811200
   PubMed Web of Science ®Google Scholar
• MetalinosGPitsavosCSkoumasJThe efficacy of the co-administration of ezetimibe with high dose statin therapy in heterozygous familial hypercholesterolemia patientsAtherosclerosis200781207
   Web of Science ®Google Scholar
• PitsavosCSkoumasITousoulisDThe impact of ezetimibe and high-dose of statin treatment of LDL levels in patients with heterozygous familial hypercholesterolemiaInt J Cardiol2009134228028118353459
   PubMed Web of Science ®Google Scholar
• PisciottaLMasturzoPBellocchioAEfficacy and safety of ezetimibe added to current therapy with statins in molecularly characterized FH patientsAtherosclerosis20067 Suppl 3554
   Web of Science ®Google Scholar
• ArteagaLIACuevasMARigottiRAHypercholesterolemia familiar heterocigota: diagnostico molecular y terapia combinada. Caso clinico. [Molecular diagnosis and combined lipid lowering therapy of heterozygous familial hypercholesterolemia. Report of one case]Rev Med Chil2007135221562120
   Google Scholar
• NaoumovaRPTosiIPatelDSevere hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: long-term follow-up and treatment responseAtherosclerosis Thromb Vasc Biol2005251226542660
   PubMed Web of Science ®Google Scholar
• LindSOlssonAGRudlingMErikssonMEggertsenGAngelinBSignificant reduction of plasma LDL-C in an ARH patient by adding ezetimibeAtherosclerosis20045 Suppl 1S85
   Web of Science ®Google Scholar
• LindSOlssonAGErikssonMRudlingMEggertsenGAngelinBAutosomal recessive hypercholesterolemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatmentJ Intern Med2004256540641215485476
   PubMed Web of Science ®Google Scholar
• Hamilton-CraigIFamilial hypercholesterolemia: walking time bombs and digging for goldMed Today200893946
   Google Scholar
• BatesTRBurnettJRvan BockxmeerFMHamiltonSArnoldaLWattsGFDetection of familial hypercholesterolaemia: a major treatment gap in preventative cardiologyHeart Lung Circ20081741141317683986
   PubMed Web of Science ®Google Scholar
• WilliamsRRSchumacherMCBarlowGKDocumented need for more effective diagnosis and treatment of familial hypercholesterolemia according to data from 502 heterozygotes in UtahAm J Cardiol1993721018D24D
   PubMed Web of Science ®Google Scholar
• WonderlingDUmans-EckenhausenMAMarksDDefescheJCKasteleinJJThorogoodMCost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The NetherlandsSemin Vasc Med2004419710415199439
   PubMedGoogle Scholar
• ThorssonBSigurdssonGGudnasonVSystematic family screening for familial hypercholesterolemia in IcelandArterioscler Thromb Vasc Biol200323233533812588780
   PubMed Web of Science ®Google Scholar
• DamgaardDLarsenMLNissenPHThe relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish populationAtherosclerosis2005180115516015823288
   PubMed Web of Science ®Google Scholar
• StarrBHadfieldSGHuttenBADevelopment of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolemia in cascade testingClin Chem Lab Med200846679180318601600
   PubMed Web of Science ®Google Scholar
• Hamilton-CraigICase-finding for familial hypercholesterolemia in the Asia-Pacific regionSeminars in Vascular Med200448792
   PubMedGoogle Scholar
• Umans-EckenhausenMDefescheJSijbrandsEScreederRKasteleinJReview of first 5 years of screening for familial hypercholesterolemia in the NetherlandsLancet200135716516811213091
   PubMed Web of Science ®Google Scholar
• KasteleinJJPAkdimFStroesESGENHANCE InvestigatorsSimvastatin with or without ezetimibe in familial hypercholesterolemiaN Engl J Med20083581431144318376000
   PubMed Web of Science ®Google Scholar
• The LIPID Study GroupLong-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-upLancet20023591379138711978335
   PubMed Web of Science ®Google Scholar
• RidkerPMDanielsonEFonsecaFAJUPITER Study GroupRosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinN Engl J Med2008359212195220718997196
   PubMed Web of Science ®Google Scholar
• OudkerkMStillmanAEHalliburtonSSEuropean Society of Cardiac Radiology; North American Society for Cardiovascular ImagingCoronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular ImagingEur Radiol200818122785280718651153
   PubMed Web of Science ®Google Scholar
• BruckertEHayemGDejagerSYauCBegaudBMild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients – the PRIMO studyCardiovasc Drugs Ther20051940341416453090
   PubMed Web of Science ®Google Scholar
• BruckertEGagneCGaudetDHomozygous familial hypercholesterolemia: a novel therapy with ezetimibeAtherosclerosis20023281
   Google Scholar
• GagneCGaudetDBruckertEEzetimibe Study GroupEfficacy and safety of ezetimibe co administered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemiaCirculation2002105212469247512034651
   PubMed Web of Science ®Google Scholar
• GagneCGaudetDBruckertEEzetimibe significantly reduces low-density lipoprotein cholesterol in homozygous familial hypercholesterolemiaJ Am Coll Cardiol2002299 Suppl B135B
   Google Scholar
• GagneCGaudetDBruckertEPonnsonnetDLipkaLleBeautAfor the Exetimibe Study GroupEzetimibe significantly reduces the low-density lipoprotein cholesterol in homozygous familial hypercholesterolemiaJ Am Coll Cardiol200239 Suppl A227A
   Google Scholar
• SchmidtHHJTietgeUJFBuettnerJLiver transplantation in a subject with familial hypercholesterolemia carrying the homozygous pW577R LDL-receptor gene mutationClin Transplant200822218018418339137
   PubMed Web of Science ®Google Scholar
• YamamatoAHarada-ShibaMEndoMThe effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapyAtherosclerosis2006861126131
   Google Scholar
• KassnerUThomasHSteinhagen-ThiessenEVogtAIntensified lipid lowering treatment with lipid-apheresis and atorvastatin coadministered with ezetimibe in two children with homozygous familial hypercholesterolemiaAtherosclerosis20045 Suppl 1120
   Web of Science ®Google Scholar
• KolovouGDDedoussisGVAnagnostopoulouKKManagement of a patient with a null low-density lipoprotein receptor mutation: a case reportAngiology200657672973217235114
   PubMed Web of Science ®Google Scholar
• UllahMAhmadSAFamilial hypercholesterolemia in a paediatric patientJ Coll Physicians Surg Pak200515957857916181585
   PubMedGoogle Scholar
• van der GrafACuffie-JacksonCVissersMNEfficacy and safety of co administration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemiaJ Am Coll Cardiol200852171421142918940534
   PubMed Web of Science ®Google Scholar
• ClaussSWaiKMKaveyREWKuehlKEzetimibe treatment of pediatric patients with hypercholesterolemiaJ Pediatr2009154686987219230898
   PubMed Web of Science ®Google Scholar
• YesteDChaconPClementeMAlbisuMAGussingyeMCarrascosaAEzetimbe as monotherapy in the treatment of hypercholesterolemia in children and adolescentsJ Pediatr Endocrinol Metab200922648749219694195
   PubMed Web of Science ®Google Scholar
• GeissHCOttoCHund-WissnerEParhoferKGEffects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statinsAtherosclerosis20055180110711215823282
   PubMed Web of Science ®Google Scholar
• CheseauxJJJotterandVAebiCHyperlipidaemia in HIVinfected children treated with protease inhibitors: relevance for cardiovascular diseasesJ Acquir Immune Syndr200230288293
   PubMed Web of Science ®Google Scholar
• FichtenbaumCJGerberJGRosenkranzSLNIAD AIDS Clinical Trials GroupPharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers;ACTG Study A5047AIDS20021656957711873000
   PubMed Web of Science ®Google Scholar
• BustiAJBainAMHallRGEffects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatinCardiovasc Pharmacol200851605610
   PubMed Web of Science ®Google Scholar
• BondiGAddition of ezetimide to ongoing therapy with rosuvastatin in HIV patients not reaching cholesterol targetsUS National Institutes of health; University of British ColumbiaVancouver BC, Canada
   Google Scholar
• GrafKDietrichTTachezyMMonitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosisMol Imaging200872687618706289
   PubMed Web of Science ®Google Scholar
• DietrichTHuckoTBourayouRHigh resolution magnetic resonance imaging in atherosclerotic mice treated with ezetimibeInt J Cardiovasc Imaging200925882783619662512
   PubMed Web of Science ®Google Scholar
• Gomez-GarreDMunoz-PachecoPGonzalez-RubioMLAragoncilloPGranadosRFernandez-CruzAEzetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effectBr J Pharmacol200915681218122719222481
   PubMed Web of Science ®Google Scholar
• KuhlencordtPJPadmapriyaPRützelSEzetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko miceAtherosclerosis20092021485718479686
   PubMed Web of Science ®Google Scholar
• MohlerERIIIShiYMooreJDiabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterolCytometry A2009751758219051240
   PubMedGoogle Scholar
• KalogirouMTsimihodimosVElisafMPleiotropic effects of ezetimibe: do they really exist?Eur J Pharmacol20106331–3627020152830
   PubMed Web of Science ®Google Scholar
• Al BadarinFJKulloIJKopeckySLThomasRJImpact of ezetimibe on atherosclerosis: is the jury still out?Mayo Clin Proc2009844353361 Comment in: Mayo Clin Proc. 2009;84(4):307–30919339654
   PubMed Web of Science ®Google Scholar
• LandmesserUBahlmannFMuellerMSimvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humansCirculation20051112356236315867181
   PubMed Web of Science ®Google Scholar
• Schmidt-LuckeCBojungaSRossigLHeeschenCDimmelerSZeiherAMDifferential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapyEur Heart J2006271182119016621868
   PubMed Web of Science ®Google Scholar
• LiuP-YLiuY-WLinL-JChenJ-HLiaoJKDifferential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammationCirculation200911913113819075102
   PubMed Web of Science ®Google Scholar
• KinlaySLow-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysisJ Am Coll Cardiol200749202003200917512355
   PubMed Web of Science ®Google Scholar
• BassAHinderliterALLeeCRThe impact of ezetimibe on endothelial function and other markers of cardiovascular riskAnn Pharmacother2009432021203019920161
   PubMed Web of Science ®Google Scholar
• VerhammePKerkhofFBuysschaertIRietzschelEde GrootECarotid intima-media thickness: more than a research tool?Acta Cardiol2010651596620306891
   PubMed Web of Science ®Google Scholar
• HowardBVRomanMJDevereuxRBEffect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trialJAMA2008299141678168918398080
   PubMed Web of Science ®Google Scholar
• FlegJLMeteMHowardBVEffect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trialJ Am Coll Cardiol200852252198220519095139
   PubMed Web of Science ®Google Scholar
• BrownBGTaylorAJDoes ENHANCE diminish confidence in lowering LDL or in ezetimibe?N Engl J Med2008358141504150718376002
   PubMed Web of Science ®Google Scholar
• DrazenJMJarchoJAMorrisseySCurfmanGDCholesterol lowering and ezetimibeN Engl J Med2008358141507150818376001
   PubMed Web of Science ®Google Scholar
• AkdimFde GrootEKasteleinJJPSimvastatin with or without ezetimibe in familial hypercholesterolemia: the authors replyN Engl J Med20083595532
   Google Scholar
• AkdimFKassteleinJJPGaudetDThe ENHANCE study and marketing ezetimibeJAMA200829923274718560001
   PubMed Web of Science ®Google Scholar
• BlakeJASimvastatin with or without ezetimibe in familial hypercholesterolemiaN Engl J Med2008359553118677798
   PubMedGoogle Scholar
• BrownBGSimvastatin with or without ezetimibe in familial hypercholesterolemia: the editorialist repliesN Engl J Med20083595532533
   Google Scholar
• ConnorWESimvastatin with or without ezetimibe in familial hypercholesterolemiaN Engl J Med2008359553018677797
   PubMedGoogle Scholar
• DavidHRJrMurgoloNJGrazianoMPSimvastatin with or without ezetimibe in familial hypercholesterolemiaN Engl J Med20083595531
   Google Scholar
• DiamondGAKaulSSimvastatin with or without ezetimibe in familial hypercholesterolemiaN Engl J Med2008359553018677796
   PubMedGoogle Scholar
• EichhornEJSimvastatin with or without ezetimibe in familial hypercholesterolemiaN Engl J Med2008359552953018677795
   PubMedGoogle Scholar
• TaylorAJVillinesTCStanekEJExtended-release niacin or ezetimibe and carotid intima-media thicknessN Engl J Med20093612113212219915217
   PubMed Web of Science ®Google Scholar
• VillinesTCStanekEJDevinePJThe ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6 – HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment durationJ Am Coll Cardiol201055242721272620399059
   PubMed Web of Science ®Google Scholar
• BerneisKRizzoMBertholdHKSpinasGAKroneWGouni-BertholdIEzetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trialEur Heart J2010311633163920525999
   PubMed Web of Science ®Google Scholar
• RizzoMRiniGBSpinasGABerneisKThe effects of ezetimibe on LDL-cholesterol: quantitative or qualitative changes?Atherosclerosis2009204233033319027905
   PubMed Web of Science ®Google Scholar
• RosseboABPedersenTRBomanKSEAS InvestigatorsIntensive lipid lowering with simvastatin and ezetimibe in aortic stenosisN Engl J Med2008359131343135618765433
   PubMed Web of Science ®Google Scholar
• Hamilton-CraigIKostnerKColquhounDWoodhouseSAt sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversyHeart Lung Circ200918534334619586799
   PubMedGoogle Scholar
• CaliffRMLokhnyginaYCannonCPAn update on the improved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) designAm Heart J2010159570570920435175
   PubMed Web of Science ®Google Scholar
• http://www.clinicaltrials.org/ (trials P025244, p05244, p05245, p04748, p02579)Accessed 2010 Jun 13
   Google Scholar
• DreierJPEndresMStatin-associated rhabdomyolysis triggered by grapefruit consumptionNeurology200462467014981197
   PubMed Web of Science ®Google Scholar
• FuxRMorikeKGundelUFHartmannRGleiterCHEzetimibe and statin-associated myopathyAnn Intern Med2004140867167215096354
   PubMed Web of Science ®Google Scholar
• Piedra LeonMGarcia UnzuetaMTOtero MartinezMAmado SenarisJARabdomiolisis asociada a tratamiento combinado ezetimiba-statina. [Rhabdomyolysis associated to combined ezetimibestatin treatment]Rev Clin Esp2007207842542617688879
   PubMedGoogle Scholar
• PetoREmbersonJLandrayMAnalyses of cancer data from three ezetimibe trialsN Engl J Med20083591357136618765432
   PubMed Web of Science ®Google Scholar
• Alsheikh-AliAAKarasRHEzetimibe, and the combination of ezetimibe/simvastatin, and risk of cancer: a post-marketing analysisJ Clin Lipidol20083138142
   Web of Science ®Google Scholar
• WaldDSBestwickJPWaldNJChild-parent screening for familial hypercholesterolemia: screening strategy based on a meta-analysisBMJ2007335762059917855284
   PubMed Web of Science ®Google Scholar
• SteinbergDThematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversyJ Lipid Res20064771339135116585781
   PubMed Web of Science ®Google Scholar
• AkdimFVisserMETribbleDLEffect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemiaAm J Cardiol2010105101413141920451687
   PubMed Web of Science ®Google Scholar
• PijlmanAHHuijgenRVerhagenSNEvaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in the NetherlandsAtherosclerosis201020918919419818960
   PubMed Web of Science ®Google Scholar
• HuijgenRVersmissenJOosterveerDMEfficacy of 15 years of genetic cascade screening for familial hypercholesterolemia in the Netherlands in prevention of coronary artery diseaseEuropean Atherosclerosis Society2010623Hamburg, Germany Abstract 1423
   Google Scholar
• RossRAtherosclerosis – an inflammatory diseaseN Engl J Med199934021151269887164
   PubMed Web of Science ®Google Scholar
• ZilversmitDBRelative atherogenicity of different plasma lipoproteinsAdv Exp Med Biol19781094559215009
   PubMedGoogle Scholar
• SmildeTJvan WissenSWollersheimHTripMDKasteleinJJPStalenhoefAJPEffect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trialLancet200135757758111558482
   PubMed Web of Science ®Google Scholar